HiFiBiO’s platform for antibody screening applied to COVID-19; plus Fundamental’s peptide mimetics for stroke, and BMS-IONpath

BioCentury's roundup of preclinical news

HiFiBiO’s antibody discovery platform
HiFiBiO Therapeutics has described in a Nature Biotechnology article its CelliGO microfluidics platform for high-throughput screening of antibodies secreted from single B cells.

Read the full 262 word article

How to gain access

Continue reading with a
two-week free trial.